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  21 
Summary 22 
 23 
Purpose of review: This article aims at reviewing the recent findings that have been made 24 
concerning the crosstalk of carbohydrate metabolism with the generation of small, dense 25 
low-density lipoprotein (sdLDL) particles, which are known to be associated with an adverse 26 
cardiovascular risk profile. 27 
Recent findings: Studies conducted during the past few years have quite unanimously shown 28 
that the quantity of carbohydrates ingested is associated with a decrease of LDL particle size 29 
and an increase in its density. Conversely, diets that aim at a reduction of carbohydrate 30 
intake are able to improve LDL quality. Furthermore, a reduction of the glycemic index 31 
without changing the amount of carbohydrates ingested has similar effects. Diseases with 32 
altered carbohydrate metabolism, e.g. type 2 diabetes, are associated with sdLDL particles. 33 
Finally, even the kind of the monosaccharide the carbohydrate intake consists of is important 34 
concerning LDL particle size: Fructose has been shown to alter the LDL particle subclass 35 
profile more adversely than glucose in many recent studies.  36 
Summary: LDL particle quality, rather than its quantity, is affected by carbohydrate 37 
metabolism, which is of clinical importance in particular in the light of increased carbohydrate 38 
consumption in today’s world. 39 
 40 
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Introduction 45 
 46 
In the past years, a close link of the quality (size and density) rather than the quantity of low-47 
density lipoprotein (LDL) particles with carbohydrate metabolism has been characterized. 48 
Due to the changes in dietary habits that took place during the past decades, in particular 49 
human carbohydrate metabolism faces numerous challenges in today’s world and may, if 50 
disturbed, affect cardiovascular health not only directly, but also by altering lipid profiles 51 
towards a more atherogenic pattern. 52 
LDL particles are heterogeneous and can be separated based on their size and density in 53 
several subclasses using ultracentrifugation, nondenaturing gradient gel electrophoresis 54 
(GGE), nuclear resonance spectroscopy (NMR) and ion mobility [1]. Based on the 55 
ultracentrifugation pattern of LDL particles, at least four major subspecies can be classified: 56 
large (LDL-I), medium (LDL-II), small (LDL-III) and very small (LDL-IV) particles with 57 
increasing density along this classification. In addition to the classification of LDL particles 58 
into distinct subclasses, measurement of the LDL peak size helps to characterize the 59 
atherogenicity of these particles and to assess the individual cardiovascular risk, particularly 60 
in patients with disturbed glucose metabolism. 61 
This article aims at throwing a light at the crosstalk between carbohydrate metabolism and 62 
the generation of these different subclasses of low-density lipoprotein particles. 63 
 64 
 65 
The impact of different LDL subclass profiles on cardiovascular health 66 
 67 
A phenotype with predominance of small, dense LDL particles is associated with an about 3-68 
fold increased risk of coronary artery disease. This has already early been shown in studies 69 
of myocardial infarction as well as coronary disease without infarction in the general 70 
population. The aim of more recent studies was to confirm this in specific populations. 71 
Patients on hemodialysis form one of these important subpopulations because they are at a 72 
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high risk for atherosclerosis. In this group, the link between sdLDL and coronary artery 73 
disease [2] and also survival [3] has recently been established.  74 
 75 
The importance of LDL subclass distribution compared to total LDL cholesterol levels 76 
One of the most important questions when considering the clinical value of LDL particle size 77 
measurements and the assessment of the risk that is associated with a specific LDL lipid 78 
profile is whether this adds relevant information to the information that is already provided by 79 
traditional lipid profiles. A systematic review published in 2009 concludes that previous 80 
studies have not “determined whether any measures of LDL subfractions add incremental 81 
benefit to traditional risk factor assessment” [4]. 82 
However, more recent studies have added relevant data on the predictive information of LDL 83 
particle size that extends its value beyond the information of traditional lipid profiles. Our 84 
group has shown that an elevation of small LDL (as assessed by GGE) was associated with 85 
a significant increase in the incidence of cardiovascular events during a 2-year follow-up in 86 
patients with non-coronary atherosclerosis independently of standard lipid measurements 87 
and other risk factors [5]. Another group demonstrated that the amount of small LDL particles 88 
in patients with acute ischemic stroke is associated with disease status, as well as total and 89 
in-hospital mortality, independently of other lipids and standard risk factors [6]. In addition, 90 
common carotid artery intima-media thickness (IMT) as a surrogate endpoint for 91 
cerebrovascular disease was shown to be independently associated with small dense LDL 92 
[7]. Similarly, another study confirmed small dense lipoprotein particles to be the strongest 93 
predictor of carotid atherosclerosis assessed by IMT compared with other lipid parameters 94 
[8]. Further, in 172 patients with type 2 diabetes mellitus, low-density lipoprotein particle size 95 
was independently associated with carotid IMT regardless of antidiabetic and lipid-lowering 96 
medications [9]. Similar findings have been obtained concerning the value of LDL particle 97 
size in predicting coronary artery stenosis by coronary CT scanning or coronary angiography 98 
[10]. Finally, in patients on hemodialysis, recent data emphasizes the superiority of LDL 99 
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particle size compared to traditional lipid profiles when identifying patients at risk for coronary 100 
artery disease [11]. 101 
 102 
Oxidation and glycation of LDL cholesterol particles 103 
Different mechanisms are proposed to contribute to the more atherogenic characteristics of 104 
small dense LDL particles. In addition to the higher susceptibility of these particles to 105 
oxidative modification [12], there is growing evidence that they are also more prone to 106 
glycation [13]. 107 
 108 
 109 
The generation of different LDL subclasses 110 
 111 
Different pathways in the processing of particles with higher density (very low-density 112 
lipoprotein (VLDL), intermediate-density lipoprotein (IDL)) are thought to be the mechanism 113 
influencing the size- and density-distribution of low-density lipoprotein particles [14]. 114 
Triglyceride availability in turn seems to play an important role in the determination of these 115 
pathways. In hypertriglyceridemia, the formation of small, dense LDL particles is favoured, 116 
while there is an increased exchange of triglycerides from triglyceride-rich lipoproteins to LDL 117 
and HDL particles in exchange of cholesteryl esters through the action of cholesteryl ester 118 
transfer protein (CETP) [15]. This process results in the generation of very low-density 119 
lipoprotein particles enriched in cholesteryl esters and gives rise to smaller, triglyceride-rich 120 
low-density lipoprotein particles. In accordance with the assumptions concerning these 121 
pathways, many studies have shown a strong correlation of increased plasma triglycerides 122 
with a decreased size and increased density of the predominant LDL subspecies. 123 
 124 
The role of insulin in VLDL secretion 125 
Concerning carbohydrate metabolism, insulin secretion as well as the tissue response to 126 
insulin seems to play a central role in the production of large, triglyceride rich VLDL particles, 127 
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and most importantly for the production of small, dense low-density lipoprotein particles. 128 
Numerous studies have assessed the question whether hyperinsulinemia or insulin 129 
resistance is the essential pathophysiologic condition to induce the hepatic VLDL 130 
overproduction [16]. From experiments conducted in cell culture, it is known that acute 131 
exposure to insulin suppresses hepatic VLDL production by many mechanisms [17, 18], 132 
however, this effect is abolished or even reversed when insulin secretion is prolonged. In 133 
contrast, a quite elegant new study that compared the production of VLDL apolipoprotein B in 134 
controls and insulin resistant individuals with patients suffering from insulinoma provides 135 
evidence that hyperinsulinema alone is not sufficient to induce VLDL apolipoprotein B 136 
overproduction [19] *. Thus, it seems that at least some degree of insulin resistance is 137 
necessary for VLDL production. In line with these findings, recent data comparing basal and 138 
insulin mediated VLDL-triglyceride kinetics in patients with type 2 diabetes with those in 139 
healthy men by hyperinsulinemic euglycemic clamp technique found that increased VLDL-140 
triglyceride concentrations in diabetic men were caused by an increase in their secretion, 141 
while the ability of hyperinsulinemia to suppress them was still preserved [20] **.  142 
 143 
 144 
Carbohydrate intake and LDL particle subclasses 145 
 146 
Interventional studies comparing the effects of low and high carbohydrate diets on LDL found 147 
that high carbohydrate diets effect LDL particle size, generating smaller, potentially more 148 
atherogenic LDL particles as compared to low carbohydrate diets. 149 
 150 
Short-term interventions 151 
Such results were observed already during a recent short-term study, where isocaloric diets 152 
with either high fat / low carbohydrate or low fat / high carbohydrate content were compared 153 
(crossover design) in twelve healthy man [21] * during 3 days. After the low fat / high 154 
carbohydrate diet, LDL particle size was significantly lower, while particle size distribution 155 
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shifted towards smaller particle size. These changes in LDL particle size and density were 156 
thought to be the consequence of an observed increase in large triglyceride rich VLDL 157 
particles and serum triglycerides, which both are of importance in the generation of small 158 
dense LDL as mentioned above. However, changes such as those observed in the above-159 
mentioned study  have not been observed in another study after just a single meal with 160 
different fat content [22]. 161 
 162 
Long-term interventions 163 
Recent dietary interventions of longer duration provided similar evidence. One study of 4 164 
weeks duration demonstrated a smaller LDL peak size in individuals after a low-fat / high-165 
carbohydrate diet compared to a high-fat / low-carbohydrate diet [23]. A long-term diet 166 
intervention over 9 months has been performed in overweight or obese middle-aged adults. 167 
Most importantly LDL size increased in this population during a low-carbohydrate diet, 168 
whereas no differences were observed during a low-fat diet. The change in body weight did 169 
not differ between these two groups [24]. Therefore, probably when LDL size is already 170 
decreased no further decrease can be expected in overweight or obese subjects during a 171 
low-fat meal. Further, a Mediterranean-style diet with decreased carbohydrate intake, but 172 
also a slight decrease in fat intake (with a shift to the intake of monounsaturated fatty acids) 173 
as well as an increase in protein intake has been shown to  increase the mean size of LDL 174 
particles [25]. 175 
 176 
 177 
Defective carbohydrate metabolism and LDL particle subclasses 178 
 179 
Early investigations already reported a more than twofold higher prevalence of the type B 180 
lipid profile (which is characterized by the predominance of smaller, denser LDL particles) in 181 
patients with type 2 diabetes mellitus (52 % of patients vs. 24 % in the control group).  182 
 183 
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LDL particles and insulin resistance 184 
The size and density of LDL particles is closely related to insulin resistance. Despite of 185 
higher weight being associated with decreased LDL particle size [26], states of insulin 186 
resistance, as the polycystic ovary syndrome (PCOS) are associated with a decreased LDL 187 
particle size independently of weight [27]. Of interest, a study that investigated the effects of 188 
genetic risk loci for type 2 diabetes or hyperglycemia on lipoprotein subclasses in nondiabetic 189 
individuals concluded that only a limited number of these risk loci significantly affect 190 
lipoprotein metabolism [28]. This supports the hypothesis that an initiation of the cascade 191 
ultimately leading to insulin resistance and type 2 diabetes is necessary for significant 192 
changes of LDL particle quality. 193 
 194 
 195 
Different carbohydrates differentially affect LDL quality 196 
 197 
Because of the increasing evidence that different carbohydrates differentially affect 198 
triglyceride metabolism and insulin resistance [29], differences in their association with LDL 199 
particle quality have been tested in recent studies. 200 
 201 
Fructose and LDL particle size 202 
Frucose is well known to increase triglyceride levels and to adversely affect insulin 203 
sensitivity. Plasma triglycerides are increased by a stimulated hepatic de novo lipogenesis 204 
[30] as well as a decreased VLDL-triglyceride clearance [31]. Both these effects are very 205 
likely to contribute to an increase in small dense LDL particles as described above. Of 206 
interest, it could be shown that such alterations as increased VLDL-triglyceride were more 207 
pronounced in healthy subjects with a family history of type 2 diabetes compared with those 208 
without such a genetic background when challenged with fructose ingestion [32]. If glucose 209 
and fructose consumption were compared directly during a 10 week diet study, indices of 210 
postprandial triglycerides (23-hour AUC, triglyceride exposure and postprandial triglyceride 211 
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peak, but not fasting triglyceride) increased after fructose, but not after glucose consumption. 212 
Concomitantly, there was an increase in small dense LDL particles [33]. Of interest, the 213 
specific effects of fructose on VLDL-triglyceride can be neutralized by combined ingestion of 214 
fat and fructose (with fat alone decreasing VLDL-triglyceride) [34] * and are gender specific 215 
with a more pronounced effect in males compared with premenopausal women [35]. 216 
Today, most fructose is consumed in the form of high fructose corn syrup, which is used as 217 
an artificial sweetener in sugar sweetened beverages in many countries. A study assessed 218 
whether there are differences in the lipid profile after consumption of high fructose corn syrup 219 
compared with the lipid profile after consumption of fructose or glucose alone [36] **. 220 
Whereas indices of postprandial triglycerides were only increased after fructose and high 221 
fructose corn syrup, small dense lipoprotein particles were increased after all the 222 
interventions. 223 
When we investigated the association of fructose consumption with LDL quality in overweight 224 
schoolchildren, we found that fructose ingestion predicts LDL particle size in this population 225 
[37]. Recently we investigated in a randomized intervention study whether the effects of 226 
fructose consumption (in the form of sugar sweetened beverages, SSB) during a short period 227 
of only three weeks differ significantly from those of other sweeteners (glucose or sucrose). 228 
Indeed, LDL particle size was significantly lower after consumption of SSB sweetened with 229 
fructose or sucrose compared with those sweetened with glucose [38] **. 230 
 231 
Glycemic index and LDL particle size 232 
Not only the kind of the monosaccharide, but also the form in which a certain quantity of 233 
carbohydrates is provided seems to influence LDL particles. Ingestion of food with a high 234 
glycemic index is associated with dyslipidemia. Plasma triglycerides have been shown to be 235 
higher in participants of a large observational study who consumed carbohydrates with a 236 
higher glycemic index – interestingly, this association was independent of age, BMI, exercise 237 
and the intake of other macronutrients [39]. Such observations could be extended to an 238 
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association of a high glycemic index with an unfavourable lipoprotein subclass profile in a 239 
more recent study [40]. 240 
 241 
 242 
Conclusion 243 
 244 
The quantity of low-density lipoprotein particles remains often unchanged when alterations in 245 
carbohydrate metabolism occur, but their quality changes. An increase in carbohydrate 246 
ingestion as well as an increase in the glycemic index is associated with a smaller LDL 247 
particle size. Furthermore, certain forms of carbohydrates also shift LDL particle subclass 248 
distribution towards a more unfavourable profile. Fructose, already in moderate amounts, 249 
adversely affects LDL size in interventional studies. Diseases with an impaired carbohydrate 250 
metabolism, as the metabolic syndrome and diabetes mellitus, have also been demonstrated 251 
to be closely associated with an abundance of smaller, denser LDL particles. 252 
LDL size and subclass distribution integrate many aspects of carbohydrate intake and 253 
metabolism with an impact on cardiovascular health that are not adequately reflected by the 254 
single measurement of its quantity.  Qualitative aspects of LDL particles and subclasses will 255 
be of increasing clinical importance in the future, in particular in the light of increased energy 256 
and carbohydrate consumption and its detrimental effects on human health. 257 
 258 
 259 
Key points 260 
 261 
- There is evidence that small, dense LDL particles are associated with a higher 262 
cardiovascular risk independently of the total LDL cholesterol level.  263 
- The amount or type of carbohydrates ingested modulates the quality rather than the 264 
quantity of low-density lipoprotein cholesterol. 265 
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- Disturbed carbohydrate metabolism, as seen in type 2 diabetes mellitus, is 266 
associated with a more unfavourable LDL particle subclass distribution. 267 
- Isocaloric ingestion of different carbohydrates affects LDL particle size differentially, 268 
with a particular decrease seen after fructose ingestion. 269 
 270 
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